ALKERMES INC
15-12G/A, 1996-07-11
PHARMACEUTICAL PREPARATIONS
Previous: USA CAPITAL LAND FUND L P, 10-Q/A, 1996-07-11
Next: COASTAL PHYSICIAN GROUP INC, PREC14A, 1996-07-11



<PAGE>
 
                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549
                                       
                                   FORM 15/A     

     CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
   12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
  REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

                               Commission File Number        0-19267
                                                     ---------------------------

                                Alkermes, Inc.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

                                64 Sidney Street
                        Cambridge, Massachusetts  02139
                                (617) 494-0171
- --------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)

      Class A 1992 Warrants to purchase 2,800 shares of Common Stock
       ("Class A 1992 Warrants")
      Class A 1995 Warrants to purchase 300 shares of Common Stock 
       ("Class A 1995 Warrants")
      Class B 1992 Warrant to purchase 5,600 shares of Common Stock
       ("Class B 1992 Warrant")
      Class B 1995 Warrant to purchase 600 shares of Common Stock 
       ("Class B 1995 Warrant")
      Incentive Warrants to purchase 77,100 shares of Common Stock
       ("Incentive Warrants")
      Affiliate Warrants to purchase 13,300 shares of Common Stock
       ("Affiliate Warrants")
- --------------------------------------------------------------------------------
           (Title of each class of securities covered by this Form)

                                 Common Stock
           1994 Class A Warrants to purchase shares of Common Stock
- --------------------------------------------------------------------------------
  (Titles of all other classes of securities for which a duty to file reports
                     under Section 13(a) or 15(d) remains)

  Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
<TABLE>
     <S>                    <C>          <C>                      <C>  
     Rule 12g-4(a)(1)(i)    [_]          Rule 12h-3(b)(1)(i)      [_]
     Rule 12g-4(a)(1)(ii)   [X]          Rule 12h-3(b)(1)(ii)     [_]
     Rule 12g-4(a)(2)(i)    [_]          Rule 12h-3(b)(2)(i)      [_]
     Rule 12g-4(a)(2)(ii)   [_]          Rule 12h-3(b)(2)(ii)     [_]
                                         Rule 15d-6               [_]

</TABLE> 
 
  Approximate number of holders of record as of the certification or notice
   date:
<TABLE>     
                      <S>                                               <C> 
                      Class A 1992 Warrants:                            84
                      Class A 1995 Warrants:                            84
                      Class B 1992 Warrant:                             0
                      Class B 1995 Warrant:                             0
                      Incentive Warrants:                               0
                      Affiliate Warrants:                               0
</TABLE>     

  Pursuant to the requirements of the Securities Exchange Act of 1934, Alkermes,
Inc. has caused this certification/notice to be signed on its behalf by the
undersigned duly authorized person.
    
Date: July 10, 1996                      By: /s/ Michael J. Landine
     -------------------------------         -----------------------------------
                                                 Michael J. Landine
                                                 Senior Vice President-Finance
                                                                                


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission